{"transactions":[{"id":710523,"issuer":{"id":7824,"kind":"organization","name":"REGENTIS BIOMATERIALS LTD."},"owners":[{"id":30775,"kind":"person","name":"Alpert Susan PHD MD","position":1,"cik":"0001204668","reported_name":"Alpert Susan PHD MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-13T21:07:38.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":24826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option grant was approved by the Board of Directors of the Issuer on June 4, 2026, subject to shareholder approval, which was obtained on July 9, 2026."},{"field":"security","element":"securityTitle","label":"F2","text":"This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on September 4, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or June 4, 2029."}],"balance_after":24826,"derivative":{"exercise_price":2.16,"exercise_date":"2026-09-04","expiration_date":"2036-06-04","underlying":"Ordinary Shares","underlying_shares":24826},"source":{"system":"sec-edgar","filing":"0001213900-26-077638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204668/000121390026077638/ownership.xml","form_type":"4"}},{"id":710388,"issuer":{"id":7824,"kind":"organization","name":"REGENTIS BIOMATERIALS LTD."},"owners":[{"id":30721,"kind":"person","name":"Ben-Elazar Pini","position":1,"cik":"0002114839","reported_name":"Ben-Elazar Pini","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-13T21:07:02.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":8313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"This option grant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026."},{"field":"security","element":"securityTitle","label":"F4","text":"This option grant is fully vested as of this date."},{"field":"security","element":"securityTitle","label":"F5","text":"To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee."}],"balance_after":8313,"derivative":{"exercise_price":0.003,"exercise_date":"2026-02-23","expiration_date":"2036-02-23","underlying":"Ordinary Shares","underlying_shares":8313},"source":{"system":"sec-edgar","filing":"0001213900-26-077636","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1912966/000121390026077636/ownership.xml","form_type":"4"}},{"id":710387,"issuer":{"id":7824,"kind":"organization","name":"REGENTIS BIOMATERIALS LTD."},"owners":[{"id":30721,"kind":"person","name":"Ben-Elazar Pini","position":1,"cik":"0002114839","reported_name":"Ben-Elazar Pini","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-13T21:07:02.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":24826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option grant was approved by the Board of Directors of the Issuer on June 4, 2026, subject to shareholder approval, which was obtained on July 9, 2026."},{"field":"security","element":"securityTitle","label":"F2","text":"This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on September 4, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or June 4, 2029."},{"field":"security","element":"securityTitle","label":"F5","text":"To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee."}],"balance_after":24826,"derivative":{"exercise_price":2.16,"exercise_date":"2026-09-04","expiration_date":"2036-06-04","underlying":"Ordinary Shares","underlying_shares":24826},"source":{"system":"sec-edgar","filing":"0001213900-26-077636","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1912966/000121390026077636/ownership.xml","form_type":"4"}},{"id":710545,"issuer":{"id":7824,"kind":"organization","name":"REGENTIS BIOMATERIALS LTD."},"owners":[{"id":30790,"kind":"person","name":"Valentine Keith","position":1,"cik":"0001289408","reported_name":"Valentine Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-13T21:06:23.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":24826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026."},{"field":"security","element":"securityTitle","label":"F2","text":"This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029."}],"balance_after":24826,"derivative":{"exercise_price":2.16,"exercise_date":"2026-08-28","expiration_date":"2036-05-28","underlying":"Ordinary Shares","underlying_shares":24826},"source":{"system":"sec-edgar","filing":"0001213900-26-077634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1289408/000121390026077634/ownership.xml","form_type":"4"}},{"id":710431,"issuer":{"id":7824,"kind":"organization","name":"REGENTIS BIOMATERIALS LTD."},"owners":[{"id":30731,"kind":"person","name":"Dykan Jeff","position":1,"cik":"0001661229","reported_name":"Dykan Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-13T21:06:00.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":24826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026."},{"field":"security","element":"securityTitle","label":"F4","text":"This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029."},{"field":"security","element":"securityTitle","label":"F5","text":"To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee."}],"balance_after":24826,"derivative":{"exercise_price":2.16,"exercise_date":"2026-08-28","expiration_date":"2036-05-28","underlying":"Ordinary Shares","underlying_shares":24826},"source":{"system":"sec-edgar","filing":"0001213900-26-077633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661229/000121390026077633/ownership.xml","form_type":"4"}},{"id":710430,"issuer":{"id":7824,"kind":"organization","name":"REGENTIS BIOMATERIALS LTD."},"owners":[{"id":30731,"kind":"person","name":"Dykan Jeff","position":1,"cik":"0001661229","reported_name":"Dykan Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to purchase ordinary shares","published_at":"2026-07-13T21:06:00.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This warrant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026."},{"field":"security","element":"securityTitle","label":"F2","text":"The warrants are currently exercisable and have a three year term."}],"balance_after":12500,"derivative":{"exercise_price":0.003,"exercise_date":"2026-02-23","expiration_date":"2029-02-23","underlying":"Ordinary Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001213900-26-077633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661229/000121390026077633/ownership.xml","form_type":"4"}},{"id":710543,"issuer":{"id":7824,"kind":"organization","name":"REGENTIS BIOMATERIALS LTD."},"owners":[{"id":30789,"kind":"person","name":"GELLER EHUD","position":1,"cik":"0001284386","reported_name":"GELLER EHUD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants to purchase ordinary shares","published_at":"2026-07-13T21:05:32.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This warrant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026."},{"field":"security","element":"securityTitle","label":"F2","text":"The warrants are currently exercisable and have a three year term."}],"balance_after":31250,"derivative":{"exercise_price":0.003,"exercise_date":"2026-02-23","expiration_date":"2029-02-23","underlying":"Ordinary Shares","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001213900-26-077631","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1284386/000121390026077631/ownership.xml","form_type":"4"}},{"id":710386,"issuer":{"id":7824,"kind":"organization","name":"REGENTIS BIOMATERIALS LTD."},"owners":[{"id":30720,"kind":"person","name":"Cohen-Arazi Efraim","position":1,"cik":"0002114591","reported_name":"Cohen-Arazi Efraim","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-13T21:01:45.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":24826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026."},{"field":"security","element":"securityTitle","label":"F2","text":"This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029."},{"field":"security","element":"securityTitle","label":"F3","text":". To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee."}],"balance_after":24826,"derivative":{"exercise_price":2.16,"exercise_date":"2026-08-28","expiration_date":"2036-05-28","underlying":"Ordinary Shares","underlying_shares":24826},"source":{"system":"sec-edgar","filing":"0001213900-26-077622","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1912966/000121390026077622/ownership.xml","form_type":"4"}}]}